Aldeyra Therapeutics (137.F) Q3 2024 Earnings

1AugConfirmed
Q4 2023
Q2 2024
Q3 2024
-0.26
-0.2
-0.14
-0.07

Details

Expected EPS
-0.191166283
Actual EPS
-0.25949
Surprise EPS
-0.07
Surprise Percent
+35.74%

Description

Aldeyra Therapeutics (137.F) has reported earnings of -0.25949 per share for Q3 2024.

0 Comments

Share your thoughts